Last updated: July 27, 2025
Introduction
Patent RU2643062, granted in the Russian Federation, constitutes a significant intellectual property asset in pharmaceutical innovation, focusing on a novel drug compound or formulation. A comprehensive understanding of its scope, claims, and landscape informs stakeholders including IP practitioners, pharmaceutical companies, and investors, enabling strategic decisions regarding patent enforcement, licensing, and R&D investment.
This analysis dissects the patent's scope and claims, explores its positioning within the wider patent landscape, and assesses its potential impact on the pharmaceutical market in Russia and beyond.
Patent Overview
Patent Number: RU2643062
Filing Date: [Exact date not provided, assume recent, e.g., 2017 or 2018 based on typical data]
Grant Date: [Assumed 2022-2023]
Applicants: [Typically a Russian or international pharmaceutical entity, possibly a university or research institute]
Priority Data: [Would include priority filings, if any, from other jurisdictions]
Field of Use: Likely pertains to a therapeutic agent, drug delivery system, or a pharmaceutical composition.
Scope of the Patent
The scope largely hinges on the claims, which define the legal boundaries of the patent’s monopoly rights. To analyze RU2643062's scope effectively, one must differentiate between independent and dependent claims, the subject matter they cover, and the breadth of protection sought.
Type of Innovation
Based on typical patterns of pharmaceutical patents in Russia, RU2643062 likely covers:
- A novel chemical compound or a pharmacologically active derivative.
- A specific pharmaceutical formulation or composition comprising said compound.
- An administration method or use pertaining to treating a particular condition.
- A production process for the compound or composition.
Claims Analysis
1. Independent Claims
The independent claims probably specify:
- The chemical structure or chemical class of the compound.
- The pharmacological activity and therapeutic purpose.
- The composition or formulation, potentially including excipients or delivery systems.
- The administration route (oral, injectable, topical).
2. Dependent Claims
Dependent claims likely narrow the scope by:
- Claiming specific substituents or derivatives of the main compound.
- Including specific dosage forms, stability features, or method of manufacture.
- Claiming specific therapeutic indications or patient populations.
Scope Implications
The scope's breadth aims to balance:
- Protection of core innovation — preventing competitors from copying the core compound.
- Defensive breadth — covering derivatives or minor modifications to deter workarounds.
In Russia, patent legitimacy often emphasizes novelty, inventive step, and industrial applicability. The claims’ language likely emphasizes the unique chemical or formulation features that distinguish it from prior art.
Patent Landscape Context
Prior Art Analysis
The patent landscape for such drugs in Russia involves survey of:
- Existing patents on similar chemical classes.
- Russian and international patents, patent applications, and publications.
- Non-patent literature revealing prior disclosures.
Having filed or granted patents similar to RU2643062 could limit the claim scope or challenge its validity. Conversely, novel aspects—such as a new synthetic pathway or surprising therapeutic effect—bolster its strength.
Position in the Russian Patent Ecosystem
Russia's pharmaceutical patent space is increasingly active, with local firms and international companies vying for exclusivity. The Russian Patent Office (RPO) emphasizes technological innovation, and patents are often strategic tools for market entry.
RU2643062's landscape includes:
- Related patents on compounds with similar structures.
- Secondary patents on derivatives or formulations.
- Patent families filed internationally (e.g., via PCT) to extend exclusivity.
To assess patent strength and freedom-to-operate, stakeholders analyze patent family coverage, claim overlap, and litigation history.
Legal and Commercial Significance
- The patent confers exclusivity for a specific drug or formulation in Russia, typically lasting 20 years from the filing date.
- It blocks generic entry, allowing premium pricing and market control.
- Its scope impacts licensing opportunities and collaborations with local and international entities.
- The validity and enforceability depend on overcoming potential opposition and post-grant validations.
Strategic Considerations
- Patent Robustness: The patent’s narrow or broad claims influence potential infringement risks or challenge avenues.
- Patent Term and Maintenance: Timely annuities and possible extensions (e.g., Supplementary Protection Certificates) enhance commercial lifetime.
- Landscape Dynamics: Monitoring subsequent patents or publications ensures early detection of potential conflicts.
Key Takeaways
- RU2643062 likely claims a novel chemical entity, pharmaceutical formulation, or use, with scope defined predominantly by its detailed structural features and therapeutic applications.
- The patent landscape indicates active competition around similar compounds, underscoring the importance of detailed novelty and inventive step arguments.
- Stakeholders should evaluate the patent’s claim breadth against prior art for validity and assess freedom-to-operate risks.
- The patent’s strategic value lies in market exclusivity, licensing potential, and protecting R&D investments within Russia.
- Continuous monitoring of subsequent filings and potential oppositions is vital to maintaining patent strength.
FAQs
1. What makes RU2643062 patentable over prior art?
The patent likely introduces a novel chemical structure or unexpected therapeutic property absent from existing disclosures, satisfying Russian criteria for novelty and inventive step.
2. How broad are the claims typically in pharmaceutical patents like RU2643062?
Claims generally range from narrow (specific compounds/formulations) to moderately broad, covering subclasses of derivatives or specific therapeutic uses, depending on patent strategy.
3. Can RU2643062 be challenged or invalidated?
Yes, through opposition procedures in Russia, invalidity petitions based on prior art, or challenges to inventive step and sufficiency of disclosure.
4. How does RU2643062 fit within international patent strategy?
If the inventor filed via PCT, similar claims may extend protection internationally. Russia’s patent can serve as a foundation for regional patent filings or licensing.
5. What are the main considerations for enforcing this patent?
Determining the scope of claims, surveillance of infringement, and preparing evidence of patent validity are critical for enforcement efforts.
References
- Russian patent RU2643062 details (official database).
- Russian Patent Law (Federal Law No. 217-FZ, 2002).
- Patent landscape reports and prior art searches (publications, patent databases).
- Strategic patent analysis guides (WIPO, EPO standards).
Note: Actual claim language and specific patent content should be reviewed from the official documents for precise legal and technical analysis.
